Clinical ischemia-reperfusion injury: Driven by reductive rather than oxidative stress? A narrative review

Ischemia-reperfusion (IR) injury remains a major contributor to organ dysfunction following transient ischemic insults. Although numerous interventions have been found effective to reduce IR injury in preclinical models, none of these therapies have been successfully translated to the clinical setti...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Biochimica et biophysica acta. Bioenergetics 2025-04, Vol.1866 (2), p.149539, Article 149539
Hauptverfasser: de Kok, Michèle J.C., Schaapherder, Alexander F.M., Bloeme - ter Horst, Jonna R., Faro, Maria Letizia Lo, de Vries, Dorottya K., Ploeg, Rutger J., Bakker, Jaap A., Lindeman, Jan H.N.
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Ischemia-reperfusion (IR) injury remains a major contributor to organ dysfunction following transient ischemic insults. Although numerous interventions have been found effective to reduce IR injury in preclinical models, none of these therapies have been successfully translated to the clinical setting. In the context of the persistent translational gap, we systematically investigated the mechanisms implicated in IR injury using kidney donation and transplantation as a clinical model of IR. Whilst our results do not implicate traditional culprits such as reactive oxygen species, complement activation or inflammation as triggers of IR injury, they reveal a clear metabolic signature for renal IR injury. This discriminatory signature of IR injury is consistent with a post-reperfusion metabolic paralysis and involves high-energy phosphate depletion, tricarboxylic acid cycle defects, and a compensatory activation of catabolic routes. Against this background, the picture emerges that clinical IR injury is driven by reductive stress. In this article, we therefore wish to elaborate on the processes contributing to reductive stress in the context of clinical IR injury and provide a better insight in potential clinical therapeutic strategies that might be helpful in restoring the redox balance. •Kidney transplantation is used as a model to elaborate the mechanisms underlying clinical ischemia reperfusion injury.•Post-reperfusion normoxic glycolysis preceeds future ischemia reperfusion injury. Persistent post-reperfusion (hypo) xanthine production implies ongoing ATP/GTP catabolism in the reperfusion phase.•Renal ischemia reperfusion injury associates with a Krebs cycle defect at the level of the oxoglutarate dehydrogenase-complex.•Comprehensive recruitment of catabolic pathways, with parallel accumulation of reducing equivalents, may further contribute to the Krebs cycle defect.•Limiting reductive overload may reduce ischemia reperfusion injury.
ISSN:0005-2728
1879-2650
1879-2650
DOI:10.1016/j.bbabio.2025.149539